Delaying Local Spread On 18/4/2020

تأخير الانتشار المحلي - 18/4/2020

تأخير الانتشار المحلي - 18/4/2020 العدد الإجمالي للحالات الايجابية لفيروس التاجي المستجد 18/4/2020

العدد الإجمالي للحالات الايجابية لفيروس التاجي المستجد 18/4/2020 فيروس التاجي المستجد-19-لبنان- 18/4/2020

The scale of 5000 is based on a realistic estimation of the capacity of the health care system.

If 5000 people are infected, about 20% would need hospital care (1000 patient), 5% would be admitted in intensive care units (250 patients), while 2-3% would need mechanical ventilation (150 patients).

Knowing that 5000 is a cumulative number starting Feb. 21as shown in figure 3. It is worth mentioning, that the 1000 patients are not expected to be all hospitalized at the same time. They will rather be progressively admitted and discharged over the considered period of time. Calculation done in terms of patient days shows that the demand generated by 5000 positive cases would remain compatible with the health system capacity.

The hospital capacity is expected to be 576 beds + 234 ICU beds + 263 ventilators, all dedicated to covid-19 patients, by April 10, 2020. Knowing that this capacity will gradually be enhanced (raising the bar of the figure 1).

Our strategy is to flatten the curve while increasing the capacity of the health care system to adequately respond to this pandemic.

Help us by following the instructions of the Ministry of Public Health and most of all STAY AT HOME.

...

148

...

ATC	Name	B/G	Ingredients	Dosage	Form	Price
J06BA02	IMMUNOREL	BioHuman	Human normal immunoglobulin - 2.5g/50ml	5%	Injectable solution	14,850,456 L.L
B05CX01	5% DEXTROSE INJECTION USP	G	Glucose - 5%	5%	Injectable solution	224,090 L.L
B05CX01	5% DEXTROSE INJECTION USP	G	Glucose - 5%	5%	Injectable solution	148,244 L.L
B05CX01	DEXTROSE 5% INJECTION USP	G	Glucose - 5%	5%	Injectable solution	158,587 L.L
B05CX01	DEXTROSE 5% INJECTION USP	G	Glucose - 5%	5%	Injectable solution	171,228 L.L
B05CX01	DEXTROSE 5% INJECTION, USP	G	Glucose - 5%	5%	Injectable solution	193,062 L.L
B05CX01	DEXTROSE 5% INJECTION, USP	G	Glucose - 5%	5%	Injectable solution	171,228 L.L
B05CX01	DEXTROSE 5% INJECTION, USP	G	Glucose - 5%	5%	Injectable solution	158,587 L.L
B05CX01	SERUFLEX DEXTROSE 5% INJECTION USP	G	Glucose - 5%	5%	Injectable solution	171,228 L.L
B05CX01	SERUFLEX DEXTROSE 5% INJECTION USP	G	Glucose - 5%	5%	Injectable solution	158,587 L.L
B05CX01	SERUFLEX DEXTROSE 5% INJECTION, USP	G	Glucose - 5%	5%	Injectable solution	171,228 L.L
B05CX01	SERUFLEX DEXTROSE 5% INJECTION, USP	G	Glucose - 5%	5%	Injectable solution	193,062 L.L
B05CX01	SOLUFLEX DEXTROSE 5% INJECTION USP	G	Glucose - 5%	5%	Injectable solution	186,167 L.L
B05CX01	SOLUFLEX DEXTROSE 5% INJECTION USP	G	Glucose - 5%	5%	Injectable solution	186,167 L.L
B05CX01	SOLUFLEX DEXTROSE 5% INJECTION, USP	G	Glucose - 5%	5%	Injectable solution	205,703 L.L
B05CX01	SOLUFLEX DEXTROSE 5% INJECTION, USP	G	Glucose - 5%	5%	Injectable solution	221,792 L.L
B05CX01	SOLUFLEX DEXTROSE 5% INJECTION, USP	G	Glucose - 5%	5%	Injectable solution	185,018 L.L
D10AE01	BENZAC AC	G	Benzoyl peroxide - 5g/100g	5%	Gel	388,370 L.L
N01BB54	EMLA	B	Prilocaine - 25mg/g, Lidocaine - 25mg/g	5%	Cream	1,763,121 L.L
D11AX01	ALOPEXY	G	Minoxidil - 50mg/ml	5%	Solution	896,343 L.L
D11AX01	ALOPEXY	G	Minoxidil - 5%	5%	Solution	896,343 L.L
D11AX01	HAIRGAINE 5	G	Minoxidil - 5%	5%	Solution	1,963,354 L.L
D11AX01	HAIRGROW	G	Minoxidil - 5%	5%	Solution	1,061,636 L.L
D11AX01	MINOXIDIL BAILLEUL	G	Minoxidil - 5%	5%	Solution	3,675,409 L.L
D01AE16	LOCERYL	B	Amorolfine - 125mg/2.5ml	5%	Nail lacquer	1,076,418 L.L
D01AE16	AMOROLFINE BGR	G	Amorolfine - 5%	5%	Nail lacquer	753,896 L.L
L01BC02	EFUDIX	B	Fluorouracil - 5%	5%	Cream	671,921 L.L
D04AB01	VERSATIS	B	Lidocaine - 5%	5%	Patch	13,085,712 L.L
D04AB01	VERSATIS	B	Lidocaine - 5%	5%	Patch	2,772,347 L.L
D04AX01	DOXIDERM	G	Doxepin (HCl) - 5%	5%	Cream	1,037,958 L.L

...

148

...